Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 31 Mar 2026 for Soleno Therapeutics INC, €127k. Read the official filing
Filing timeline
BuySaleMeredith Manning
Insider track record
Disclosed buys
0
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+50.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Meredith Manning: trading record in brief
All filings by Meredith Manning on record concern Soleno Therapeutics Inc. The record holds 8 filings, for trades running from 17 July 2024 to 27 March 2026.
The open-market record consists of 4 sales worth €240k, with no purchase. Outside the open market, there are 4 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 31 March 2026, reports an open-market sale of €127k in Soleno Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Meredith Manning
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
4,864 shares@ US$30.03752.9% of flowCommon StockSEC:0001752631-26-000002:0
2,100 shares@ US$31.038423.6% of flowCommon StockSEC:0001752631-26-000002:1
558 shares@ US$31.71876.4% of flowCommon StockSEC:0001752631-26-000002:2
1,922 shares@ US$49.95Common StockSEC:0001752631-25-000004:0
668 shares@ US$65.9691100.0% of flowCommon StockSEC:0001415889-25-009296:0
13,600 shares0Common StockSEC:0001415889-25-001936:0
40,000 shares0Common StockSEC:0001415889-24-019812:0
7 of 7 declarations
